» Articles » PMID: 39451888

Effect of a Physical Exercise Intervention on Physical Function Parameters and Blood Analytical Changes in Lung Cancer Survivors: A Feasibility Study

Overview
Journal Clin Pract
Publisher MDPI
Specialty General Medicine
Date 2024 Oct 25
PMID 39451888
Authors
Affiliations
Soon will be listed here.
Abstract

Lung cancer carries a high burden of systemic symptoms, including in survivors, leading to a reduced quality of life (QoL). We assessed whether a 12-week multicomponent supervised exercise programme, including muscular strength and aerobic training, was beneficial in patients who had undergone surgery for early non-small cell lung cancer (NSCLC) in terms of physical performance, QoL, and metabolic and nutritional analytical parameters. Physical performance was measured by gait speed, handgrip strength, 30 s sit-to-stand (30s-STS) test repetitions, distance covered in the 6 min walk test (6MWT), and the Short Physical Performance Battery (SPPB) score. QoL was assessed with the EORTC-QLQ-C30 questionnaire. Blood glucose, cholesterol, triglycerides, total proteins, albumin, pre-albumin, creatinine, c-reactive protein, insulin-growth factor 1 (IGF-1), and the haemoglobin and hematocrit percentages were measured before and after the intervention in order to observe any beneficial effects related to metabolic markers. After the intervention, the mean scores for the 6MWT ( < 0.001), STS ( < 0.001), 6MWT ( < 0.01), and SPPB ( < 0.01) had significantly improved. However, handgrip strength and nutritional analytical were unchanged. The EORTC-QLQ-C30 functions and symptoms significantly improved after the intervention ( < 0.05 and < 0.01, respectively). A significant decrease in cholesterol, triglycerides, and IGF-1 and a significant increase in pre-albumin in blood was also observed post-intervention ( < 0.05). This supervised, community-based 12-week multicomponent was feasible (adherence rate 70.35%) and provided benefits not only to physical performance but also to the quality of life of patients with NSCLC.

References
1.
Bray F, Laversanne M, Sung H, Ferlay J, Siegel R, Soerjomataram I . Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024; 74(3):229-263. DOI: 10.3322/caac.21834. View

2.
Whitehead A, Sully B, Campbell M . Pilot and feasibility studies: is there a difference from each other and from a randomised controlled trial?. Contemp Clin Trials. 2014; 38(1):130-3. DOI: 10.1016/j.cct.2014.04.001. View

3.
Sommer M, Trier K, Vibe-Petersen J, Missel M, Christensen M, Larsen K . Perioperative rehabilitation in operation for lung cancer (PROLUCA) - rationale and design. BMC Cancer. 2014; 14:404. PMC: 4053552. DOI: 10.1186/1471-2407-14-404. View

4.
Chen H, Tsai C, Wu Y, Lin K, Lin C . Effect of walking on circadian rhythms and sleep quality of patients with lung cancer: a randomised controlled trial. Br J Cancer. 2016; 115(11):1304-1312. PMC: 5129819. DOI: 10.1038/bjc.2016.356. View

5.
Pasqua F, Geraneo K, Nardi I, Lococo F, Cesario A . Pulmonary rehabilitation in lung cancer. Monaldi Arch Chest Dis. 2013; 79(2):73-80. DOI: 10.4081/monaldi.2013.95. View